OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
Kazuomi Kario, Akihiro Nomura, Noriko Harada, et al.
European Heart Journal (2021) Vol. 42, Iss. 40, pp. 4111-4122
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Digital Therapeutics in Hypertension: Evidence and Perspectives
Kazuomi Kario, Noriko Harada, Ayako Okura
Hypertension (2022) Vol. 79, Iss. 10, pp. 2148-2158
Open Access | Times Cited: 68

World Heart Federation Roadmap for Digital Health in Cardiology
Jasper Tromp, Devraj Jindal, Julie Redfern, et al.
Global Heart (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 59

Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kazuomi Kario, Yook Chin Chia, Saulat Siddique, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 3, pp. 213-223
Open Access | Times Cited: 41

Virtual management of hypertension: lessons from the COVID-19 pandemic–International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
Nadia Khan, George S. Stergiou, Stefano Omboni, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 8, pp. 1435-1448
Closed Access | Times Cited: 41

Digital therapeutics in the clinic
Philana Phan, Samir Mitragotri, Zongmin Zhao
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 39

Short- to long-term blood pressure variability: Current evidence and new evaluations
Keisuke Narita, Satoshi Hoshide, Kazuomi Kario
Hypertension Research (2023) Vol. 46, Iss. 4, pp. 950-958
Closed Access | Times Cited: 25

Self-Monitoring of Blood Pressure and Feedback via Mobile App in Treatment of Uncontrolled Hypertension: the SMART-BP Randomized Clinical Trial
Minjae Yoon, Taeho Hur, Sung Ji Park, et al.
Mayo Clinic Proceedings (2025)
Closed Access | Times Cited: 1

Cost-effectiveness of digital therapeutics for essential hypertension
Akihiro Nomura, Tomoyuki Tanigawa, Kazuomi Kario, et al.
Hypertension Research (2022) Vol. 45, Iss. 10, pp. 1538-1548
Open Access | Times Cited: 35

Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023
Kazuomi Kario, Naoko Tomitani, Tzung‐Dau Wang, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2561-2574
Closed Access | Times Cited: 20

Hypertension management before and under the COVID-19 pandemic: lessons and future directions
Yoichi Nozato, Kōichi Yamamoto, Hiromi Rakugi
Hypertension Research (2023) Vol. 46, Iss. 6, pp. 1471-1477
Open Access | Times Cited: 17

Recent developments in machine learning modeling methods for hypertension treatment
Hirohiko Kohjitani, Hiroshi Koshimizu, Kazuki Nakamura, et al.
Hypertension Research (2024) Vol. 47, Iss. 3, pp. 700-707
Closed Access | Times Cited: 8

The Impact of Digital Health Solutions on Bridging the Health Care Gap in Rural Areas: A Scoping Review
Karla C. Maita, Michael J. Maniaci, Clifton R. Haider, et al.
The Permanente Journal (2024) Vol. 28, Iss. 3, pp. 130-143
Closed Access | Times Cited: 7

Effects on Adherence to a Mobile App–Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial
Yuxi Li, Yanjun Gong, Bo Zheng, et al.
JMIR mhealth and uhealth (2021) Vol. 10, Iss. 2, pp. e32251-e32251
Open Access | Times Cited: 34

The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
Kazuomi Kario, Ji‐Guang Wang, Yook Chin Chia, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 9, pp. 1112-1120
Open Access | Times Cited: 26

Effectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application
Mark J. Pletcher, Valy Fontil, Madelaine Faulkner Modrow, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 10, pp. 1025-1025
Open Access | Times Cited: 24

Information Needs and Communication Strategies for People with Coronary Heart Disease: A Scoping Review
Clara C. Zwack, Carlie Smith, Vanessa Poulsen, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1723-1723
Open Access | Times Cited: 16

Different Home Blood Pressure Thresholds to Predict Perfect 24-Hour Ambulatory Blood Pressure Control in Treated Hypertension Based on an “All-in-One” Device
Kazuomi Kario, Naoko Tomitani, Satoshi Hoshide, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2464-2472
Closed Access | Times Cited: 16

Efficacy of a WeChat-Based Multimodal Digital Transformation Management Model in New-Onset Mild to Moderate Hypertension: Randomized Clinical Trial
Yijun Wang, Fuding Guo, Jun Wang, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e52464-e52464
Open Access | Times Cited: 14

Sleep blood pressure measured using a home blood pressure monitor was independently associated with cardiovascular disease incidence: the Nagahama study
Yasuharu Tabara, Takeshi Matsumoto, Kimihiko Murase, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 10, pp. 1695-1702
Closed Access | Times Cited: 5

Mobile health technologies in the prevention and management of hypertension: A scoping review
Abdulhammed Opeyemi Babatunde, Deborah Abisola Ogundijo, A O Afolayan, et al.
Digital Health (2024) Vol. 10
Open Access | Times Cited: 5

Digital redesign of hypertension management with practice and patient apps for blood pressure control (PIA study): a cluster-randomised controlled trial in general practices
Frauke Leupold, Arian Karimzadeh, Thorben Breitkreuz, et al.
EClinicalMedicine (2022) Vol. 55, pp. 101712-101712
Open Access | Times Cited: 22

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
Kazuomi Kario, Noriko Harada, Ayako Okura
Hypertension Research (2022) Vol. 45, Iss. 12, pp. 1899-1905
Open Access | Times Cited: 21

Latest hypertension research to inform clinical practice in Asia
Kazuomi Kario, Masaki Mogi, Satoshi Hoshide
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 555-572
Open Access | Times Cited: 19

Home blood pressure-lowering effect of digital therapeutics in hypertension: impact of body weight and salt intake
Kazuomi Kario, Naoko Tomitani, Noriko Harada, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1181-1187
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top